BEX2 is overexpressed in a subset of primary breast cancers and mediates the inhibition of apoptosis of breast cancer cell lines through nerve growth factor/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [49]. Here, NFKB1 is linked to breast cancer.